You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Dow
Baxter
McKesson
Express Scripts

Last Updated: October 3, 2023

Investigational Drug Information for PF-04965842


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for PF-04965842?

PF-04965842 is an investigational drug.

There have been 24 clinical trials for PF-04965842. The most recent clinical trial was a Phase 3 trial, which was initiated on December 7th 2017.

The most common disease conditions in clinical trials are Dermatitis, Atopic, Dermatitis, and Eczema. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There are six US patents protecting this investigational drug and one hundred and forty-nine international patents.

Recent Clinical Trials for PF-04965842
TitleSponsorPhase
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic DermatitisPfizerPhase 2
Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy ParticipantsPfizerPhase 1
A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy ParticipantsPfizerPhase 1

See all PF-04965842 clinical trials

Clinical Trial Summary for PF-04965842

Top disease conditions for PF-04965842
Top clinical trial sponsors for PF-04965842

See all PF-04965842 clinical trials

US Patents for PF-04965842

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PF-04965842 ⤷  Try a Trial Substituted indazoles for treating tendon and/or ligament injuries NOVARTIS AG (Basel, CH) ⤷  Try a Trial
PF-04965842 ⤷  Try a Trial Aza-indazole compounds for use in tendon and/or ligament injuries NOVARTIS AG (Basel, CH) ⤷  Try a Trial
PF-04965842 ⤷  Try a Trial Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof Pfizer Inc. (New York, NY) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Dow
Baxter
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.